Ibrutinib combined with bendamustine/rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): safety analysis in the HELIOS trial Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Cramer, Paula
  • Chanan-Khan, Asher
  • Fraser, Graeme
  • Demirkan, Fatih
  • Silva, Rodrigo Santucci
  • Pylypenko, Halyna
  • Grosicki, Sebastian
  • Janssens, Ann
  • Pristupa, Aleksander
  • Goy, Andre
  • Mayer, Jiri
  • Dilhuydy, Marie-Sarah
  • Loscertales, Javier
  • Barlett, Nancy
  • Avigdor, Abraham
  • Rule, Simon
  • Sun, Steven
  • Phelps, Charles
  • Mahler, Michelle
  • Salman, Masha
  • Howes, Angela
  • Hallek, Michael

publication date

  • September 1, 2015